📊 Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
30
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
42%
💰 Capital Raise
55%
• Critical: only 0.7 months cash remaining
📉 Score Deterioration
50%
• Score rose 45 points recently (worsening)
• Score in HIGH risk zone (67/100)
💹 Market Data
Market Cap$54.53M
Shares Outstanding6.26M
Float4.67M
Cash$14.14M
Debt$1.86M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 83.0% shares (2025Q4 vs prior)
38 institutional holders · 9.31M shares
#1
CITADEL ADVISORS LLC
2.61M shares
#2
VANGUARD GROUP INC
2.46M shares
#3
BlackRock, Inc.
654.0K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest332.5K
Days to Cover1.9
% of Float7.1%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Oct 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for FGNX
📊 FGNX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 FGNX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.